Pillstats
Rx only · Injection, Solution · Subcutaneous

Glucagon Injection, Solution

Brands: Gvoke Hypopen 0.5 Mg Auto-Injector · Gvoke Hypopen 1 Mg Auto-Injector · Gvoke Kit · Gvoke Pfs 1 Mg Pre-Filled Syringe · Glucagon

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US4 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)4832
US makers1 labelers
Packages7
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 6 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$537.77$1075.54$1613.31$2151.09Dec 2025Feb 2026Jul 2026
$1868.455
Latest avg · Jul 22, 2026
+3%
Since Dec 17, 2025
1
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

12K23K35K47K2025 Q12025 Q22025 Q32025 Q42026 Q1
28K
Rx · 2026 Q1
9.3K
Units dispensed
-15%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Xeris Pharmaceuticals, Inc.unknown7SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.